<SEC-DOCUMENT>0001193125-14-457967.txt : 20141231
<SEC-HEADER>0001193125-14-457967.hdr.sgml : 20141231
<ACCEPTANCE-DATETIME>20141231161211
ACCESSION NUMBER:		0001193125-14-457967
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20141223
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20141231
DATE AS OF CHANGE:		20141231

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1230

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27598
		FILM NUMBER:		141318777

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d844598d8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML><HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Washington, DC 20549 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT
STYLE="white-space:nowrap">8-K</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CURRENT
REPORT </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Pursuant to Section&nbsp;13 or 15(d) of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>The Securities Exchange Act of 1934 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Date of Report (Date of earliest event reported) December&nbsp;23, 2014 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman" ALIGN="center"><B>IRIDEX CORPORATION </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Exact name of registrant as specified in its charter) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>0-27598</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>77-0210467</B></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of incorporation)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Commission</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>File Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>(IRS Employer<BR>Identification No.)</B></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>1212 Terra Bella Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Mountain View, California 94043 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address of principal executive offices, including zip code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(650) 940-4700 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Registrant&#146;s telephone number, including area code) </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Former name or former address, if changed since last report) </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below): </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><FONT STYLE="FONT-FAMILY:WINGDINGS">&#168;</FONT></TD>
<TD ALIGN="left" VALIGN="top">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </TD></TR></TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;5.02</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. </B></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"><I>Resignation of Director </I></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On December&nbsp;23, 2014, James B. Hawkins resigned from the Board of
Directors (the &#147;Board&#148;) of IRIDEX Corporation (the &#147;Company&#148;), the Audit Committee of the Board and the Nominating and Governance Committee of the Board, in each case effective December&nbsp;31, 2014. </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I>(d)</I></TD>
<TD ALIGN="left" VALIGN="top"><I>Appointment of Director </I></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On December&nbsp;31, 2014, Dr.&nbsp;George Marcellino was
appointed to the Board and the Audit Committee of the Board, in each case effective immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Marcellino will receive
standard compensation and option grants available to non-employee members of the Board and committees of the Board, including an initial option to purchase 15,000 shares of the Company&#146;s common stock which vests ratably over a 36-month period
following the effective date of the grant. In addition, it is expected that Dr.&nbsp;Marcellino will execute the Company&#146;s standard form of indemnification agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company&#146;s press release dated December&nbsp;31, 2014 regarding Dr.&nbsp;Marcellino&#146;s appointment is attached hereto as Exhibit
99.1 and is incorporated herein by reference. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="10%" VALIGN="top" ALIGN="left"><B>Item&nbsp;9.01.</B></TD>
<TD ALIGN="left" VALIGN="top"><B>Financial Statements and Exhibits. </B></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top">Exhibits </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated December 31, 2014.</TD></TR>
</TABLE>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>
<TD WIDTH="6%"></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><B>IRIDEX CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ JAMES H. MACKANESS</P></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">James H. Mackaness</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Chief Operating Officer
and Chief Financial Officer</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: December&nbsp;31, 2014 </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT INDEX </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="border-bottom:1.00pt solid #000000; width:37.30pt; font-size:8pt; font-family:Times New Roman">Exhibit&nbsp;No.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="border-bottom:1.00pt solid #000000; width:37.25pt; font-size:8pt; font-family:Times New Roman">Description</P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>99.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Press Release dated December 31, 2014.</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d844598dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"><B>For Immediate Release</B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right">


<IMG SRC="g844598image000.jpg" ALT="LOGO">
</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Medical Laser Veteran George R. Marcellino, Ph.D. Appointed to IRIDEX Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Mountain View, Calif., December&nbsp;31, 2014</B> &#151; IRIDEX Corporation (NASDAQ:IRIX) announced today that it has appointed
ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr.&nbsp;Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B.
Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Will Moore, IRIDEX President and CEO, said,
&#147;We couldn&#146;t be more pleased that George Marcellino is joining the Board of Directors at such an exciting time at IRIDEX. His technical and executive resumes are equally impressive and his insights into our key markets &#150; particularly
glaucoma &#150; will be invaluable in the coming year and beyond.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Since the inception of OptiMedica in 2004 through its merger with
Abbott Medical Optics in 2013, Dr.&nbsp;Marcellino has held diverse executive positions including vice president of marketing and chief financial officer. He currently serves as vice president of clinical sciences and global advocacy. Prior to
OptiMedica, from 1988 to 2003, Dr.&nbsp;Marcellino held senior research, sales and marketing roles at Santa Clara, CA-based Coherent, Inc, and its subsequent embodiment Lumenis, Ltd. His prior medical and laser experience includes management and
director level roles at Laserscope, Inc., Cooper Laseronics, Inc. and Oximetrix &#150; all located in the San Francisco Bay area. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Moore
continued, &#147;I would like to thank Jim Hawkins for his service to IRIDEX and its shareholders during his tenure on the Board. His guidance in areas of strategy and keen attention to matters of corporate governance has been a great value to the
management team and the entire organization.&#148; </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About IRIDEX </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile
laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is
dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of
approximately 70 independent distributors into over 100 countries. For further information, visit the IRIDEX website at http://www.iridex.com/. </P>

<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Safe Harbor Statement </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This announcement contains forward-looking statements within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and
Section&nbsp;21E of the Securities Act of 1934, as amended, including those statements concerning the markets in which the Company operates, trends in treatment and product usage, product plans and future product releases, and the Company&#146;s
strategic plans and objectives. These statements are not guarantees of future performance and actual results may differ materially from those described in these forward-looking statements as a result of a number of factors. Please see a detailed
description of these and other risks contained in our Annual Report on Form 10-K for the fiscal year ended December&nbsp;28, 2013, which was filed with the Securities and Exchange Commission. Forward-looking statements contained in this announcement
are made as of this date and will not be updated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="34%"></TD>
<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B><U>IRIDEX Contact:</U></B></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"><B><U>Investor Relations Contact:</U></B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Jim Mackaness</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Matt Clawson</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">CFO&nbsp;&amp; COO</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">Pure Communications, Inc.</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">650-940-4700</TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">949-370-8500</TD></TR>
<TR STYLE="font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"><FONT STYLE="font-size:8pt">&nbsp;</FONT></TD>
<TD VALIGN="bottom">matt@purecommunicationsinc.com</TD></TR>
</TABLE>
</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>g844598image000.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g844598image000.jpg
M_]C_X``02D9)1@`!``$`8`!@``#__@`?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$``@&!@<&!0@'!P<*"0@*#18.#0P,#1L3%!`6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$`:(```$%`0$!`0$!```````````!`@,$!08'"`D*"P$``P$!
M`0$!`0$!`0````````$"`P0%!@<("0H+$``"`0,#`@0#!04$!````7T!`@,`
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?H1``(!`@0$`P0'!00$``$"=P`!`@,1
M!`4A,08205$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H
M*2HU-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&
MAXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76
MU]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_``!$(`&(`;`,!$0`"$0$#$0'_V@`,
M`P$``A$#$0`_`/?Z`"@`H`*`,C6/$>GZ+\D[F2XV[_)CQN"_WF)("K[L0*`/
M,=7^-]M%,\-FR.XZ):1&<Y]W)5?R#?6A:Z('IJS(/QFUDJVW2]5P3D-^Y&!]
M/+_K6GLJG\K,_:T_YD:NF_'&V,ZQ7P:W)/2\@,?X;T+#\UK-IQT9HFGL>EZ'
MXJTW74C\B0)(XRBE@1(.Y1@2&_`Y'<"@#<H`*`"@`H`*`"@`H`*`.1\<^,(O
M#.F2B.9([D1[VD9=PA0G`./XF)R%7N02>`:`/G^[NM0\6NTU]));Z8S^8MN'
MRTQ_OR-_$WO^0`KLP^%=1<T]CDKXGD]V&YTGA[PG-=:AIUDEG)96MXWRS&(@
M,H&203U.!Q77*M2I0:IVNCEC2J59KVE['I3>!O#\7B>UTW[$6@>QD=BTK;BP
M=`&SGK@G\ZX?;U6K\QV^QIIVL<)XJ\&RZ?KEQIUK:S7UJ(A.O[O>50Y'S8'8
M@UV4L1"I"U6QR5*$X3_=G%0+>^&YOMNBN7M]P>6R=B4?'<=P?0CD=C6-?"<J
MYJ?W?Y&M'%7?+4^\]W^'WCJ#Q1I\2/+NF;.PM][(ZH_^V!SD?>'/J!YYW'<T
MP"@`H`*`"@`H`ANKF*SM)KF9ML4*%W/H`,F@#YG\8ZG-XE\5O:S9\BU/GW2Y
MX,Q'"?1%PGX,>]=&'I>TGKLC"O4]G'3=G5_\(!JKZ>;B![>XF1`[6:DB3;[9
M&&_#@]JZ_KL7I:QR_5)+6]SVJRFM[VPMKB%1Y3(KQC&-O'Z'M7F'HF5/_P`C
MY9?]@^;_`-&1U2^$G[1N'9'ND.%P/F;V%24>+R^"=0U2>YU,-!8P74SR6T$@
M)DD4DD851QQ7HPQ<:<%&U['!/"RG)RO8X33KN;PKXPAE200VUY,(IL,"L<JM
M\KYZ<'\P6'>L,332:J1VD:X>;UIO='TUIMZNHZ;!=JNSS%RR'JC="OX'(_"N
M4ZBW0`4`%`!0`4`87B^41^'W1@2DLL:.,?P;@6_\=!H`^:M!=[J"YOY,M->7
M#R,>Y)/^.:]7!)1I.3/,Q;<JG*CWCPKHWB:'2[:VU4VGV:,#R5<M]HA'8!E_
ME^%<%:5.4KP.ZDIQC:9?\3:U+X3T&XD::-RZLMLV`)/,(XRO1N>21CZ5%.#G
M)1152:A%MG,Z5J=G+HUG>R7):)=$NO/D>3+%_,4-D^I;/YBKE%)M+N1&5TF^
MQK^!M>G\3>&8[0S1O/`OEW$DWS,R_P`)V]\CN>^>M%:GR3:6PZ,^>";W+FO:
M5XD^Q7":)+:"21<-+(6\]QZ!CP/Y>F*BGR)^_L5/F:]S<\`\264B:5=V\L;1
M36YY1ARC*>1_.O5Q'+.@W'U/,H7A629[Y\-;YK[PHDS9(8K(#GJ7C5V_\>9J
M\<]8[&@`H`*`"@`H`P?%Z.VA_NP"?.13G/\`$=G_`+-0!\V>$_-_LZ"*`,;B
M.8HH4<[]W&/QQ7JX9Q>':EMJ>9B%)5U;?0^H]);4O[,B;5Q;K>8RX@SM'Y]Z
M\MVOH>DKVU.0UN\TW6M96?3[./5Y[-#'YMP^VQMB3RS-T9NG`ST[5:O%:NQ+
MLWM<Y.ZU'1T\50K<:X[7H0J=0@C06T+Y&$$6"&3KDG/;GCC54IN-U'3\3)U(
M*5F]?P.ET^XL](UJ#5=4MH+0E#$=2T_YK.Y4X^_C[AR`>>/>LG=JR?R-%9.[
M1W=Q)/+8-)ISP/,RYB:0DQGZD=OI69H?-7C.2\C.LMJ8"WI9A,!P-Q/;V]*]
M:3BL,^7:QY:4GB/>WN>Q_"BV-MX/B5@0P2)2<]<0H>G;KC\*\D]0[N@`H`*`
M"@`H`IZK9?VAI5S:!MK2(0C?W6_A/X'!H`^:M\OA?X@2[H=B3S+?0(W0,&RR
M?4,&7_@-=>&E?FI/J<N(C9JHNA[?IUE<>-+.+4-5OD.FRC*:?9N0GTE?@L1W
M7@?6N=^X[=3=>\K]#IX[*P;3A9QVT#66W:(@@,>/3'2HN69C:3H4=PEL-/L5
MM]K*Z>2FW=E<`\=>?UI\SO>XN56M8U8K*RL[(VT5M##:@',:H%3'?CI2'L<Y
M=:&_A^&74?#U_%96Z@R26=P<VK#U'>,^XX]JN]]&3:VQX3XJU%_&/BR.%D\@
M7D@FN%7YO*B51G/KP,UTU_W=.-+KNSFH_O*CJ]-D?1?AG3WTW0+>&6,1S/F6
M1/[K,<[?PSC\*XSK->@`H`*`"@`H`*`/+/BKX'35+%]1MOW4B-YHD`_U,F`-
MQ_V&``8]B`W3=1MJ@WT9Y1IVKW<,LNF7K36-^AQ+#O*!^.N!UR*]6A6IUM)I
M<QYE:E.C\#?*>BZ?\2KO3/#<&EV^GQ"X@C$4<Y;Y0!P"5QU_&IE@KSO?0I8R
MT;6U.DTO4[*3X>_:;FXW#[)<+<,6^8REAG_@1)!'U%<4Z=JO(D=D)WI\[.>M
M/BCJ,6B-975E'=76S8MPS8!XQEEQR?IUKLE@?>T>AR1QEHZK4\XU#6&M(([%
M))KF=B!#:*Q;+=OE[5K6J4J&J2YC*E"I6T;T/0/A;X!F%PVKZH!([N'D;J&9
M3D1KZJI`)/0D`#A3GR92<FY2W/4C%17*CVFD,*`"@`H`*`"@`H`0@$$$9'I0
M!Y[XQ^%NG>((S)!$`ZCY%#;&C_W'YP/]D@CTVT@/*K_P3XKT%RD4R7$(.`MX
MAB;\&Y0_@U=,,55AI>_J<\\-3EK:QGF#Q0I"'1(CGG*WL>P^_P![]:V^N.]^
M57,_JFEN9V+-EX8\6:U((T,-M&>HM09W_-?E'XL*SGBZLM%H7#"TX[ZGI7@_
MX0VNE/\`:=0W&1A\^YMTLGJ&8<(/9>3W8CBN7S.G;1'2^-1XHM;'3XO"$*JJ
M/ME6-4RJ@#:`&XQU_3M0!U=N9C;1&X"B?8/,"]`V.<>V:`):`"@`H`IW^KZ;
MI7EC4-0MK3S<[//F5-V,9QD\XR/SH`JQ^*/#\LBQQ:YI[R-T5;I"3^&:`&_\
M);X;QG_A(--Q_P!?<?\`C0!9L]<TG4'V66J6=R_]V&=7/Z&@"M_PEGAP$C^W
M]-X_Z>T_QH`<WBCP^BH6US3U$B[D)ND&X9(R.>1D$?A0!7/B+PF90YUC2#(.
M`WVB/(_6@#8M[FVNHO,MIXI8^FZ-@P_2@#-/BOPZ"0=>TT$<'-TG'ZT`+'XJ
M\/2R+''KNG.[$!56Z0DD]`.:`'S^)-"M9W@N-:L(9HSM>-[E%93Z$$\4`6?[
M4T_^SO[1^W6_V'&?M'FKY>,X^]G'7B@`L=5T_4U<Z??V]V(R`Y@E5]N>F<'B
M@"W0!B>*])T[5/#]Z-0L;>Z\JWD:/SHPQ0[3R,].@Z>E`'D?[/>E:?=V6L7=
MS8V\US%+&J221AF0%3D`GI0!G1Z)I7_#2#:9_9MK]@WD_9O*'E_ZC=]WIUYH
M`WOC/X1\.Z-X9BUK3+&#3=2CN$2-K8>5O!SD8'IC.?:@#SE+:+4?%_@DWUC"
M#?1V_P!H7R@HG_?,NY@.I90,GO0!ZQ\;=#TJV^'@GM]-M89;>>-(FCB52BDG
M(&!TYZ4`7OAMX2\.:C\-M&FO-"T^>:6$EY)+=&9OF/4XS0!QOC_0Y?A3K5AX
ME\)2/:6=Q(8YK,,3%N'.,?W6`/';'%`&1K4.CZK\9/#<UIIUNEAJ26L[P",;
M&WY)R.A]#]*`/3O%?@WPKJD\'A^PL[/2]<=?MEK/#:`;0C#))7'KC&:`,+XU
M^`8=0T0^)+"UC6_M!NN_+3!FC[L?4KU^F?2@#+T[X@1:Q\+['PQIFGP3:_=_
M\2];01CRU&.9B.F,<_7/I0!ZQX/\*6'@_P`/6VF6<48D5!Y\RK@S28Y8_CG'
MH*`-Z@"AKG_(OZE_U[2?^@F@#R/]G3_D#:Y_UWB_]!-`&)J5@^I_M(3V<=]<
MV+R/Q<6S!9$Q;YX)!ZXQ^-`%1K5;#XL)HOQ%N+K5;/=MM)[B=@@#'Y'(Z$'H
M?0T`:OQ`BC@^.WA:&%%CBC^R*B*,!0)3@`4`=G\=/^2:S?\`7S#_`.A4`;'P
MJ_Y)AH/_`%P/_H34`<A^T)>P1^%=,LF?]_+=^:J_[*HP)_-A0!Y[=:,W_"?>
M#-(O&EB9K*SCD,3E'3.3P1R",T`>PZ9X!/AWX@6VM6MU<S:<MC)%-)>W9E=&
MW`C&[G&,T`;_`(Q\4:=X:\+SZC=!;A)%\N&`'/VAV'"CU![^U`'S_H;ZE\*/
M'VG7FLV2007D(:1%&0D3GD`GHRG&1[8[T`?3\4B31)+$X>-U#*RG((/0T`/H
M`Y[Q;;^)KRP^R>'?[,`GCDCN&OFD!4$`*4V@YZMG/M0!P_P]\">-?`C7$$<V
MASVETX:7=+*74@$#;\@'IUH`HK\._'R^/_\`A,?M'A\W^XMY7FS>7]S9C[F>
ME`'5?$CX?/XYT.V\I[>#6;;&R5B1&0?O*2`3CN..WO0!Q$OPJ^(%QK6DZM<Z
MKHT]WIBQI"SR2_,(VRN[]WS]:`.G\:^%_'?C'P_#I,KZ#!&2LD[)+-G>&.`N
M4/RXV^^<T`/\/:#\2/#_`(>M-$MI_#:P6RE4F8SN^,D]-H!Y-`#;'X4S7_B.
M/Q!XQUHZQ>1D%($B\N%,<@8[@'MQ[YH`Q=:^'7CS5_'$'BDW.@Q7-LR&&,23
M;,(>,_)D^_-`&SK>B_%+7=%N]*N;OPW#!=(8Y'A,X?:>H&5/4<4`56\`^+9_
M%^BW]W)HL^DZ/MBM;0R2X1!@;\;<&3`!ZXR!0!J_%/P/JOC>RL+73?[/C^SN
MSM-=.ZNO&,+M4C![Y]!0!K^`M*\3:%H::5XAGL)X[5$CM9+5G+%1GA]RCH-H
B&/?-`'5T`%`!0`4`%`!0`4`%`!0`4`%`!0`4`%`!0!__V3\_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
